Private, individualized care begins by listening closely to your concerns, priorities and health goals.
A Connected Women’s Journey
Weight loss, nutrition and wellness—together.
Explore our physician-guided Total Woman Weight-Loss Program, created to coordinate medical screening, nutrition, body-composition goals, aesthetic support and women’s wellness.
Women’s hormone care evaluates symptoms, life stage, health history and goals. Menopausal hormone therapy is the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause for appropriate candidates, but the formulation, route and duration require individualized risk assessment.
Concerns it may address
Hot flashes or night sweats
Vaginal dryness, discomfort or urinary symptoms related to menopause
Sleep or mood disruption during the menopause transition
Bone-health considerations in selected patients
Symptoms that may reflect thyroid, anemia, medication or another condition
Candidacy
Who may—or may not—be a candidate
Who may be considered
Many healthy symptomatic women younger than 60 or within 10 years of menopause onset may have a favorable benefit-risk profile, but candidacy is individual. Age, uterus status, migraine, clotting, cancer and cardiovascular history change the plan.
When treatment may not be appropriate
Systemic hormone therapy may be unsuitable with unexplained vaginal bleeding, certain estrogen-sensitive cancers, prior blood clots, stroke, heart attack, liver disease or other contraindications. Evaluation and alternative options are required.
At a glance
Treatment facts
These are practical planning ranges, not promises. Your consultation determines the exact plan.
Treatment time
Consultation about 30–60 minutes; testing is individualized
Comfort / anesthesia
No anesthesia for consultation
Typical downtime
None for consultation
When changes may appear
Symptom response varies over weeks; follow-up is required
How long results may last
Individualized with periodic reevaluation
Treatments commonly considered
Ongoing monitoring rather than a fixed series
Your visit
What happens during treatment
Evaluate
The provider reviews menstrual or menopause stage, symptoms, contraception needs, medical history and current medicines.
Plan & treat
Testing is targeted; hormone levels are not always required to diagnose typical menopause. Preventive screening and bleeding history are checked.
Review & follow up
If therapy is appropriate, route, dose, progesterone need, nonhormonal options and monitoring are discussed through shared decision-making.
Informed choice
Important risks, limitations and alternatives
Risks & limitations
Risk depends on age, timing, route, dose, duration and medical history. Systemic therapy may increase risks of blood clots, stroke, gallbladder disease and—depending on regimen and duration—breast cancer. Estrogen without adequate endometrial protection can increase uterine-cancer risk in a woman with a uterus.
Alternatives to discuss
Nonhormonal prescription therapies for hot flashes
Vaginal moisturizers, lubricants or selected local therapies
Sleep, mood, thyroid or other targeted medical evaluation
Gynecology or menopause-specialist referral for complex history
Clinical judgment
Why provider experience matters
Hormone care is not a pellet or lab-value sales protocol. Experienced supervision chooses the safest route, protects the endometrium when needed, evaluates abnormal bleeding and revisits benefit and risk over time.
Identity Aesthetics approach
Diagnosis and anatomy before a product or device
Conservative planning with candid limitations
Licensed-provider supervision and complication readiness
In-office and telehealth boundaries stated clearly
Access & cost
In-office versus telehealth
Initial and follow-up consultations may be available in-office or by telehealth for patients physically located in Texas or Florida, subject to law and clinical appropriateness. Examination, imaging or labs may be required.
Pricing: Consultation required. Cost depends on visit type, testing, medication, monitoring and insurance or pharmacy coverage.
When a prescription or compounded preparation is clinically appropriate, the dispensing pharmacy, facility classification and current license status matter. Compounded medications are not FDA-approved drug products.
“Bioidentical” does not automatically mean safer. FDA-approved estradiol and micronized progesterone options exist; compounded products have different oversight and evidence limitations.
Do I need hormone testing?
Not always. Typical menopause can often be diagnosed clinically. Testing is used when age, symptoms or the differential diagnosis makes it useful.
Can I start by telehealth?
Often, in eligible states, but abnormal bleeding, breast or pelvic concerns and some prescriptions require in-person evaluation or local testing.
Medical-content evidence review: July 30, 2026. Content is written for patient education and structured from current primary regulatory, labeling and professional sources. It has not been individualized to your medical history. Product labeling and guidance can change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.
Your next step
Make an informed plan
Bring your goals, questions, medication list and prior treatment history. We will help you decide whether Hormone Optimization for Women—or an alternative—makes sense.